TP53 and neoplasm: Somatic alterations consistent with sporadic urothelial carcinoma: moderate copy number gain of PRDM1 at 6q21: PRDM1; Single copy deletion of TP53 at 17p13.1; tumor is likely sporadic, no germline driven LOH